Since both Myc and EBV may enhance genomic instability (see later) then other epigenetic and/or genetic changes that enhance tumour progression (e.g. resistance to damaged DNA or hypoxia) will rapidly ensue and be fixed by further natural selection. The gene discussed is MYC; the disease is neoplasm.